English
  • Warning: Illegal string offset 'stockName' in Drupal\five_paisa\Controller\StockDetailController->getData() (line 348 of modules/custom/five_paisa/src/Controller/StockDetailController.php).
  • Notice: Uninitialized string offset: 0 in Drupal\five_paisa\Controller\StockDetailController->getData() (line 348 of modules/custom/five_paisa/src/Controller/StockDetailController.php).
  • Warning: Illegal string offset 'NSEcode' in Drupal\five_paisa\Controller\StockDetailController->getData() (line 349 of modules/custom/five_paisa/src/Controller/StockDetailController.php).
  • Notice: Uninitialized string offset: 0 in Drupal\five_paisa\Controller\StockDetailController->getData() (line 349 of modules/custom/five_paisa/src/Controller/StockDetailController.php).
  • Notice: Undefined index: current_date in Drupal\futures_option\Controller\FuturesController->getOptionData() (line 398 of modules/custom/futures_option/src/Controller/FuturesController.php).
  • Warning: array_column() expects parameter 1 to be array, string given in Drupal\five_paisa\MFHoldingService->MFShareholdingTable() (line 33 of modules/custom/five_paisa/src/MFHoldingService.php).
  • Warning: array_multisort(): Argument #1 is expected to be an array or a sort flag in Drupal\five_paisa\MFHoldingService->MFShareholdingTable() (line 34 of modules/custom/five_paisa/src/MFHoldingService.php).
  • Warning: array_slice() expects parameter 1 to be array, string given in Drupal\five_paisa\MFHoldingService->MFShareholdingTable() (line 36 of modules/custom/five_paisa/src/MFHoldingService.php).
  • Warning: Invalid argument supplied for foreach() in Drupal\five_paisa\MFHoldingService->MFShareholdingTable() (line 52 of modules/custom/five_paisa/src/MFHoldingService.php).
  1. Home
  2. Stocks
  3. Bafnaph Share Price
  • Chart
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • Bafna Pharmaceuticals

    Small Cap
    ₹83.71
    -1.28 (-1.51%)
    01 October, 2024 16:04 BSE: 532989 NSE: BAFNAPHISIN: INE878I01022

    Start SIP in Bafna Pharmaceuticals

    Start SIP

    Bafna Pharmaceuticals Performance

    Day Range

    • Low 83
    • High 88
    ₹ 83

    52 Week Range

    • Low 73
    • High 113
    ₹ 83
    • Open Price88
    • Previous Close85
    • Volume13513

    Bafna Pharmaceuticals Share Price

    • Over 1 Month +3.76%
    • Over 3 Month +10.92%
    • Over 6 Month +6.84%
    • Over 1 Year +0.19%

    Bafna Pharmaceuticals Key Statistics

    P/E Ratio 724.6
    PEG Ratio -7.4
    Market Cap Cr
    Price to Book Ratio 2.4
    EPS 3.1
    Dividend 0
    Relative Strength Index 56.07
    Money Flow Index 72.7
    MACD Signal -0.34
    Average True Range 3.83
    Bafna Pharmaceuticals Financials
    IndicatorJun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 334128414242
    Operating Expenses Qtr Cr 323931373635
    Operating Profit Qtr Cr 13-2468
    Depreciation Qtr Cr 111112
    Interest Qtr Cr 111011
    Tax Qtr Cr 000000
    Net Profit Qtr Cr -11-3265
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 156119
    Operating Expenses Annual Cr 141100
    Operating Profit Annual in Cr 1116
    Depreciation Cr 55
    Interest Annual Cr 22
    Tax Annual Cr 00
    Net Profit Annual Cr 711
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr 95
    Cash from Investing Activity Annual Cr -15-7
    Cash from Financing Annual Activity Cr -110
    Net Cash Flow Annual Cr -68
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 8173
    Fixed Assets Annual Cr 5242
    Total Non Current Assets Annual Cr 5342
    Total Current Assets Annual Cr 9487
    Total Assets Annual Cr 148130
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 3431
    ROE Annual % 915
    ROCE Annual % 1016
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 1016
    IndicatorJun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr
    Operating Expenses Qtr Cr
    Operating Profit Qtr Cr
    Depreciation Qtr Cr
    Interest Qtr Cr
    Tax Qtr Cr
    Net Profit Qtr Cr
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr
    Operating Expenses Annual Cr
    Operating Profit Annual in Cr
    Depreciation Cr
    Interest Annual Cr
    Tax Annual Cr
    Net Profit Annual Cr
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr
    Cash from Investing Activity Annual Cr
    Cash from Financing Annual Activity Cr
    Net Cash Flow Annual Cr
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr
    Fixed Assets Annual Cr
    Total Non Current Assets Annual Cr
    Total Current Assets Annual Cr
    Total Assets Annual Cr
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs
    ROE Annual %
    ROCE Annual %
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin %
    Invest in Bafna Pharmaceuticals

    Bafna Pharmaceuticals Technicals

    EMA & SMA

    Current Price
    ₹83.71
    -1.28 (-1.51%)
    pointer
    • Bullish Moving Average
    • ___
    • 9
    • Bearish Moving Average
    • ___
    • 7
    • 20 Day
    • ₹82.19
    • 50 Day
    • ₹82.98
    • 100 Day
    • ₹84.97
    • 200 Day
    • ₹87.98
    • 20 Day
    • ₹81.25
    • 50 Day
    • ₹82.80
    • 100 Day
    • ₹85.23
    • 200 Day
    • ₹88.87

    Bafna Pharmaceuticals Resistance and Support

    PIVOT
    ₹85.
    Resistance
    First Resistance 85.99
    Second Resistance 87.00
    Third Resistance 87.99
    RSI 56.07
    MFI 72.70
    MACD Single Line -0.34
    MACD 0.55
    Support
    First Support 83.99
    Second Support 83.00
    Third Supoort 81.99

    Bafna Pharmaceuticals Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 1,226 122,600 100
    Week 8,070 807,020 100
    1 Month 8,109 810,886 100
    6 Month 5,507 550,673 100

    Bafna Pharmaceuticals Result Highlights

    Bafna Pharmaceuticals Synopsis

    NSE-Medical-Generic Drugs

    Bafna Pharmaceutical belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 152.47 Cr. and Equity Capital is Rs. 23.66 Cr. for the Year ended 31/03/2024. Bafna Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 28/03/1995 and has its registered office in the State of Tamil Nadu, India. Company’s Corporate Identification Number(CIN) is L24294TN1995PLC030698 and registration number is 030698.
    Market Cap 201
    Sales 144
    Shares in Float 0.28
    No of funds
    Yield
    Book Value 2.49
    U/D Vol ratio 1.1
    LTDebt / Equity 13
    Alpha -0.01
    Beta 0.4

    Bafna Pharmaceuticals Shareholding Pattern

    Owner NameJun-24Mar-24Dec-23Sep-23
    Promoters 88.3%88.3%88.43%88.74%
    Individual Investors 7.37%7.47%7.66%6.87%
    Others 4.33%4.23%3.91%4.39%

    Bafna Pharmaceuticals Management

    Name Designation
    Mrs. S Hemalatha Chairperson & Executive Director
    Mrs. Akila C Raju Non Exe.Non Ind.Director
    Ms. R Chitra Ind. Non-Executive Director
    Mr. B Kamlesh Kumar Ind. Non-Executive Director
    Mr. P K Sundaresan Ind. Non-Executive Director

    Bafna Pharmaceuticals Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Bafna Pharmaceuticals Corporate Action

    Date Purpose Remarks
    2024-08-13 Quarterly Results
    2024-05-29 Audited Results
    2024-02-12 Quarterly Results
    2023-11-09 Quarterly Results
    2023-08-11 Quarterly Results

    Bafna Pharmaceuticals MF Shareholding

    Name Amount(cr)

    Bafna Pharmaceuticals FAQs

    What is Share Price of Bafna Pharmaceuticals ?

    Bafna Pharmaceuticals share price is ₹83 As on 01 October, 2024 | 15:50

    What is the Market Cap of Bafna Pharmaceuticals ?

    The Market Cap of Bafna Pharmaceuticals is ₹198 Cr As on 01 October, 2024 | 15:50

    What is the P/E ratio of Bafna Pharmaceuticals ?

    The P/E ratio of Bafna Pharmaceuticals is 724.6 As on 01 October, 2024 | 15:50

    What is the PB ratio of Bafna Pharmaceuticals ?

    The PB ratio of Bafna Pharmaceuticals is 2.4 As on 01 October, 2024 | 15:50

    Q2FY23
    Open Free Demat Account

    Be a part of 5paisa community - The first listed discount broker of India.

    +91
     

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5Paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.